Related by context. All words. (Click for frequent words.) 69 Accessed #/#/# [001] 68 Hematologic Malignancies 68 Biological Therapy 67 Biochemical Pharmacology 67 Nanotechnology Characterization Laboratory 66 Successfully Completes Phase 66 #:#-# [006] 66 #:#-# [001] 66 Developmental Therapeutics 66 #:#-#,# CrossRef Medline [002] 65 #:#-# [024] 65 #:#-#,# [003] 65 Completes Patient Enrollment 65 number NCT# ClinicalTrials.gov 65 Vaccine Immunology 65 #-# Full Text 65 Asthma Intervention 65 Islet Transplantation 65 Arch Neurol 64 #:#-#,# Medline 64 Anticancer Agents 64 ARRY # 64 Female Urology 64 Molecular Cancer 64 Pediatric Diabetes 64 Prolongs Survival 64 Pediatric Inflammatory Bowel Disease 64 Demonstrates Sustained 64 Tumor Microenvironment 64 #:#-# [023] 64 Am J Epidemiol 64 #:#-#,# [002] 64 Initiates Clinical Trial 64 #:# -# [003] 64 Anticancer Drug 64 HDL Selective Delipidation 63 ASCO GI 63 Psychiatry #:#-# [002] 63 J Nutr 63 Epidemiological Studies Unit 63 Pediatric Otolaryngology 63 Peer Reviewed Medical 63 Molecular Basis 63 J Clin Endocrinol Metab 63 NCI Cancer 63 Thromb Haemost 63 Hematological Malignancies 63 Individualized Therapy 63 Cardiovascular Magnetic Resonance 63 J Clin Oncol 63 General Psychiatry #:#-#,# 63 Bone Marrow Transplantation 62 Translational Biology 62 Arthritis Musculoskeletal 62 Biostatistical 62 Gastrointestinal Oncology 62 antibody blinatumomab MT#/MEDI-# 62 Crit Rev 62 Abstract Accepted 62 Clinical Virology 62 #:#-# [020] 62 Pharmacother 62 Neuro oncology 62 Hematological 62 Initiates Phase III 62 Microbial Pathogenesis 62 Phase III multicenter 62 Molecular Carcinogenesis 62 Experimental Therapeutics Program 62 TIMI Study Group 62 Neuroimmunology 62 #:# -# [004] 62 Thrombosis Research 62 Common Toxicity Criteria 62 Receives Orphan Drug Designation 62 Biological Effects 62 ASGCT 62 Cellular Immunology 62 Multiple Ascending Dose 62 INSPIRE Trial Phase III 62 Inflammatory Arthritis 62 Initiates Phase II 62 Ph.D. D.Sc. 62 Pulmonary Diseases 62 Autoimmune Diseases 62 Cell Signalling 62 Mammography Screening 62 Preclinical Studies 62 See CLINICAL PHARMACOLOGY 62 #:#-# [031] 62 Leila Y. 62 Bipolar Disorders 62 Chicago Multidisciplinary Symposium 62 AAPOS 62 Reports Preclinical Data 62 Pediatric Endocrinology 62 #:# -# [005] 61 Awarded Qualifying Therapeutic 61 Statistical Genetics 61 Cancer Immunotherapy 61 Research Programs CDMRP 61 #:#-# [033] 61 Granted Orphan Drug 61 BCIRG 61 Translational Oncology 61 Initiates Clinical 61 Endocrinol 61 Molecular Pathogenesis 61 SNS# T 61 Systemic Sclerosis 61 Phase Ib Clinical Trial 61 Psychiatric Epidemiology 61 JAK2 Inhibitor 61 Presents Positive 61 Phase 2b RESTORE CLI 61 FASEB J. 61 Cancer Incidence Mortality 61 Reduces Mortality 61 Phase 2b Clinical Trial 61 Nat Rev 61 Panzem ® 61 Clinical Psychopharmacology 61 Cutaneous Oncology 61 #:#-# [035] 61 CALGB 61 AACR IASLC Joint 61 OSUCCC 61 Announce Initiation 61 Presents Preclinical Data 61 Chronic Lymphocytic Leukemia CLL 61 Behavioral Neurobiology 61 Initiates Phase 2b 61 Clinical Practice Guideline 61 Clinical Therapeutics 61 Urologic Oncology 61 Tjeerdema chairs 61 ThermoDox ® clinical 61 Refractory Angina 61 #:#-# [007] 61 Small Molecule 61 Announce Collaboration Agreement 61 Neuromuscular Disorders 61 Pancreas Cancer 61 Prednisone Against Refractory 61 Tumor Biology 61 #:#-#,# CrossRef Medline [001] 61 Protease Inhibitor 61 Oral Calcitonin 61 Immunobiology 61 Ispinesib SB # 61 RNAi Therapeutic 61 Antibody Drug Conjugate 61 Evaluation Program CTEP 61 PhD MGH 61 Am J Geriatr 60 Hsp# Inhibitor 60 Experimental Hematology 60 Physiological Chemistry 60 Lymphatic Research 60 Drug Shows Promise 60 initiated Phase Ib 60 Services #:#-#,# Abstract 60 NCIC CTG 60 Oncologic 60 Molecular Virology 60 Neuro Oncology 60 #:#-#,# CrossRef 60 Artificial Organs 60 Molecular Biomarkers 60 Intervention Effectiveness 60 GW# [003] 60 Inflammatory Diseases 60 AACR #st Annual Meeting 60 Postdoctoral Position 60 Gynecological Oncology 60 Pediatric Rheumatology 60 Ann Oncol 60 ANN INTERN MED 60 MD Moross Institute 60 EMBO J. 60 #:#-# [019] 60 Collaborators Present 60 Renal Transplantation 60 HCV Protease Inhibitor 60 Clinical Trials Consortium 60 lymphoid malignancies 60 Therapeutic Radiation 60 Bayer HealthCare Onyx Pharmaceuticals 60 #:#-# [040] 60 Genetics Laboratory 60 Cell Transplant 60 Signal Transduction 60 Distinguished Scientist Award 60 Investigator Initiated 60 Paediatric Allergy 60 Neurochemistry 60 #:# -# [002] 60 Glickman Urological 60 Initiates Enrollment 60 Biomolecular Screening 60 Improve Diagnosis 60 Psychiatry #:#-# [001] 60 Metabolic Disease 60 Sipuleucel T 60 Molecular Oncology 60 Gynecological Cancer 60 Neurodegenerative Disorders 60 pralatrexate injection folate analogue 60 Cancer Res 60 Investigative Pathology 60 NIAID Laboratory 60 Diabet Med 60 Clinical Translational 60 RNA Therapeutics 60 Oncogene 60 Psychiatric Services #:#-#,# 60 #nd Annual Meeting 60 CA# [006] 60 Surgery Urology 60 Immunomedics Announces 60 Nuclear Receptors 60 Imaging Biomarkers 60 Teratology 60 Clinical Outcome 60 Scheie Eye Institute 60 Obstet Gynecol 60 Predoctoral 60 peer reviewed journal Annals 60 Submits NDA 60 Neurovirology 60 Immunotherapeutic 60 Principle Investigator 60 Urologic Cancer 60 Demonstrates Significant 60 Anti Infective 59 Aethlon Medical Announces 59 Colposcopy 59 AMEX RGN 59 ORWH 59 multicenter phase 59 Cytopathology 59 Initiate Phase 59 Allergic Diseases 59 Phase 1b clinical trials 59 Therapeutic Intervention 59 Phase Ib II 59 NSABP 59 Cell Signaling 59 #:#-# [037] 59 Pediatric Gastroenterology 59 Pediatric Neurology 59 BZA CE 59 Clinical Proteomics 59 Epidemiol 59 Br J Haematol 59 Phase #b/#a clinical 59 J Neurosurg 59 Late Breaker 59 MBBCh 59 #:#-#,# [001] 59 Cardiac Rhythm 59 SPORE grant 59 brivanib 59 Orqis Medical 59 Gynecol Oncol 59 Tanespimycin 59 AUDIO PROVIDED BY 59 Pharmacology Toxicology 59 Founding Scientist 59 #:# -# [006] 59 essential thrombocythemia ET 59 Prospective Randomized 59 Neurosurg 59 NSABP B 59 Patient Registry 59 Identifies Potential 59 Solid Tumor 59 Pharmacoepidemiology 59 Functional Neurosurgery 59 Thoracic Oncology Program 59 Tuberculosis Vaccine 59 Biospecimen 59 Breast Brachytherapy 59 ACNP 59 High Throughput Biology 59 #:#-# [010] 59 Theriogenology 59 Neurotherapeutics 59 Toxicological Sciences 59 Metabolic Disorders 59 Guidelines Recommend 59 Molecular Origins 59 Chemoprevention 59 Environ Health Perspect 59 Small Molecule Drug 59 Vaccine Adjuvant 59 Clinical Trial Data 59 Rigshospitalet Copenhagen Denmark 59 Mucosal Immunology 59 Receives Orphan Drug 59 Child Neurology 59 Regeneration Medicine 59 Immune Disease 59 Gastric Cancer 59 Psycho Oncology 59 Human Neural Stem 59 Survivorship Program 59 DMD DMSc 59 Geochimica et Cosmochimica Acta 59 Kinase Inhibitor 59 Anti Tumor 59 CNS Disorders 59 CALGB # [002] 59 MassGeneral Institute 59 Begins Dosing 59 Immunodeficiency 59 FRACP 59 Novel Inhibitor 59 Files Investigational 59 Receives Fast Track 59 Poster Discussion 59 Technology Studies InHealth 59 Pediatric Pulmonology 59 BiTE Antibody 59 Abdominal Imaging 59 Bundesministerium für Bildung und 59 Atherosclerosis Research 58 Autoimmune Disease 58 Pulmonary Allergy 58 Emergency Medicine Residency 58 Transplant Immunology 58 Neurotology 58 Intervention Trial GAIT 58 Psoriasis Drug 58 Antisoma AS# 58 Therapeutic Targets 58 SCAI Annual 58 Advanced Melanoma 58 Carcinogenesis 58 lexidronam injection 58 Autoimmunity 58 Novel Therapeutic 58 #:#-# [028] 58 Molecular Genetic 58 Transplantation Surgery 58 NIMH Mood 58 Urologic Nursing 58 STRIDE PD 58 Test Detects 58 Xenotransplantation 58 #st Annual Meeting 58 Cancer Incidence 58 Mayo Clinic Rochester MN 58 Arthritis Rheum 58 Adult Stem Cell Therapy 58 NHGRI Division 58 SPL# Gel vaginal microbicide 58 Cancer Vaccines 58 Current Author Addresses 58 Digestive Kidney Diseases 58 Nutritional Metabolism 58 Author Affiliations 58 Paediatric Infectious Diseases 58 Exherin 58 NCIC Clinical Trials 58 Neuropharmacology 58 J Rheumatol 58 Psychosocial Oncology 58 sarcoma melanoma 58 Estrogen Receptor 58 Neonatal Medicine 58 novel histone deacetylase 58 Ceflatonin R 58 CrossRef Medline 58 Valortim TM 58 Hedgehog Pathway Inhibitor 58 Endocrine Practice 58 GTC recombinant form 58 Clinical Oncology JCO 58 Cellular Therapy ISCT 58 Cytometry 58 R vitespen 58 Preclinical Study 58 Critical Reviews 58 Physician Scientist 58 Arch Pediatr Adolesc Med 58 Cardiovascular Therapeutics 58 Free Full Text 58 Mitchell Krucoff 58 NABTT 58 pharmacogenomic translational research 58 Phase III AFFIRM 58 abstr 58 Hodgkin lymphoma HL 58 en santé du Québec 58 Licenses Novel 58 TNFerade TM 58 Translational Neuroscience 58 Hematology Molecular Pathology 58 Presents Preclinical 58 #:#-# [032] 58 Multicenter Phase 58 Cancers Symposium 58 Biologic Therapy 58 BiTE R 58 Hospitals Leuven Belgium 58 Vaccine Protects Against 58 Diagnostic Immunology 58 Psychiatry #:#-# [003] 58 Laryngeal Cancer 58 Cervical Pathology 58 Proc Am Soc 58 Oral Fingolimod 58 ISPOR 58 Mouse Models 58 3 registrational trial 58 Paleobiology 58 Hematopathology 58 Postdoctoral Fellowship 58 Common Terminology Criteria 58 Pregnancy Outcomes 58 Preventive Oncology 58 Acta Psychiatrica Scandinavica 58 Edge STudy 58 Cardiovascular Imaging 58 novel therapeutic antibodies 58 Gastroenterology Hepatology 58 OHRI 58 Novel Therapeutics 58 SWOG 58 Selective Electrochemical Tumor Ablation 58 Andre Terzic 58 HDL Mimetic Peptide 58 Clinical Hematology 58 Data Registry NCDR 58 Cellular Therapies 58 Mitochondrial Medicine 58 Psychosocial Aspects 58 Announces Poster Presentations 58 NIH NHLBI 58 Ann Rheum Dis 58 MGd 58 Cardiovascular Metabolic 58 Ann Emerg Med 58 Diabetes Endocrinology 58 Biotherapy 58 Pediatric Psychopharmacology 58 Clinical Antipsychotic Trials 58 Grid caBIG 58 Nasdaq PPHM 58 Confirms Efficacy 58 Adjuvant Chemotherapy 57 Cancer Biomarkers 57 MD MHSc 57 Demonstrates Efficacy 57 Pediatric Nephrology 57 doi #.# 57 targeted antifolate 57 Maven Semantic 57 Renal Cancer 57 Therapeutic Competitors companiesandmarkets.com adEgemonye 57 Kidney Disorders 57 Pathology Informatics 57 Immune Therapy 57 Thoracic Oncology 57 CHAMPION PCI 57 Gynecologic Oncologists 57 Cancer Immunology Immunotherapy 57 Gynecologic Oncology Group 57 Molecular Genetics Laboratory 57 Immune Tolerance Network 57 Cervical Cancer Detection 57 Oncol 57 Multicentre 57 Connective Tissue Oncology 57 HHSN#C 57 Postdoctoral Fellowship Program 57 Molecular Epidemiology 57 GVAX ® 57 Therapeutic Radiation Oncology 57 Prostate Disease 57 Oral Presentation 57 GLOBOCAN 57 PF # [002] 57 DOI #.#/s#-#-#-# 57 Carotid Revascularization Endarterectomy vs. 57 Neurological Diseases 57 DOI #.#/hep.# 57 Papillomavirus 57 Clinical Trial Results 57 EMBO Molecular Medicine 57 PROTECT AF 57 Genitourinary Medical 57 Myelodysplastic Syndromes 57 BY WILLA J. 57 M.D. Ph.D. 57 Radiation Therapy Oncology 57 Solid Malignancies 57 e# [005] 57 PANVAC VF 57 Digestive Diseases 57 Phase III ADT 57 Paediatric Endocrinology 57 Behavioral Biology 57 Physiology Seminar 57 coronary stent merged 57 Neuroepidemiology 57 FDA Accepts 57 Neuroanatomy 57 Minimally Invasive Therapy 57 Aggressive Reduction 57 IgG1 monoclonal antibody 57 Kinase Inhibitors 57 ICAAC IDSA 57 antibody MT# 57 Digital Mammographic Imaging 57 Acute Decompensated Heart Failure 57 TASKi2 57 LUX Lung 57 Musculoskeletal Diseases 57 Tesmilifene 57 Dr. Jeffrey Peipert 57 personalized cellular immunotherapy 57 Human Mutation 57 MAGE A3 ASCI 57 UM Comprehensive Cancer 57 Metastatic Melanoma 57 Polymorphisms 57 Diabetologia 57 DAIDS 57 Cardiovascular Pharmacology 57 Molecular Endocrinology 57 Cardiac Arrhythmia 57 Clinical Trial Evaluating 57 Scripps Genomic Medicine 57 Flight Attendant Medical 57 oncolytic virus therapies 57 Resubmission 57 Cardiovascular Radiology 57 ALN HPN 57 REVIVE Diabetes 57 BiTE antibody MT# 57 Therapeutics TCT 57 Developmental Therapeutics Program 57 AE# vaccine 57 XIENCE V Stent System 57 Pharmacogenomic 57 Radiation Oncology Biology 57 Computational Genomics 57 experimental therapeutics 57 FMedSci 57 Genomics Consortium 57 Teva Provides Update 57 Initiates Dosing 57 treat secondary hyperparathyroidism 57 BLP# Liposome Vaccine 57 multicenter Phase 57 Toxicogenomics 57 Diabetes Complications 57 Cellular Biochemistry 57 Reproductive Toxicology 57 Childhood Fetal 57 NIH NIAID 57 ExTRACT TIMI 57 EnVivo Pharmaceuticals Inc. 57 Therapeutic Protein 57 Radiation Oncologists 57 Clinical Outcomes 57 Cardiometabolic 57 Screening Trial 57 NIAID NIH 57 doi #.#/j.#-#.#.#.x 57 Develops Novel 57 R lenalidomide 57 Jose Baselga 57 name Biospherics 57 Leukemia Lymphoma 57 PI3K/Akt pathway inhibitor 57 FOLOTYN ® 57 HDAC Inhibitor 57 SBIR Grant 57 iSBTc 57 Protein Expression 57 journal Gene Therapy 57 Molecular Pharmacology 57 Fast Track Status 57 huN# DM1 57 Molecular Therapeutics 57 MD FRCPC 57 Study ADCS 57 ENTOCORT EC 57 Sapacitabine 57 Vascular Disease Foundation 57 Therapeutic Advances 57 USDA CSREES 57 Clinical Guideline 57 Allergy Cardiovascular 57 Schizophrenia Treatment 57 Rigel R# 57 Nutrition Metabolism 57 Current Controlled Trials 57 Cholesterol Levels SPARCL 57 evaluating mipomersen 57 Uterine Cancer 57 HER2 Positive 57 Breast Oncology 57 Lancet Oncol 57 Tyrosine Kinase Inhibitors 57 Logo http:/www.newscom.com/cgi-bin/prnh/#/Chai Garam 57 Atul Singhal 57 #:#-# [029] 57 ZYBRESTAT TM 57 Molecular Mechanisms 57 Vulnerable Plaque 57 DDS MSD 57 Risk Stratification 57 Experimental Immunology 57 Myoblast 57 Genes Identified 57 Cheminformatics 57 Clinical Trials Unit 57 Mohs Surgery 57 Study Shows Benefits 57 TransVax ™ 57 Progenitor Cells 57 Vaccine Shows Promise 57 Panzem R 57 Ovarian PLCO Cancer 57 Experimental Therapeutics 57 Biochemical Genetics 57 Intramural Research 57 Islet Cell 57 REGiMMUNE 57 Diabetes Digestive 57 Orthopsychiatry 57 COBRE 57 Seasonal Influenza Vaccine 57 Kosan dependence 56 Genes Discovered 56 Clinic Taussig Cancer 56 Recommends Approval 56 Phase III Pivotal 56 Prenatal Diagnosis 56 PhD RPh 56 Potent Inhibitor 56 journal Antimicrobial Agents 56 Clinical Physiology 56 ASM Biodefense 56 Distinguished Scientist 56 Schizophrenia Bulletin 56 Commercialization Assistance Program 56 Phase 2b Trial 56 Cell Transplantation 56 Novel Treatments 56 Crit Care Med 56 Clinical Genetics 56 FIND THIS STUDY 56 Procyon Biopharma 56 Maxine Dunitz Neurosurgical Institute 56 Acute Stroke 56 Study Demonstrates 56 Keystone Symposium 56 Antimicrobial Chemotherapy 56 Gerontological 56 Lenore Launer 56 ICON7 56 Developmental Genetics 56 CYT# potent vascular disrupting 56 Human Molecular Genetics 56 Ocular Inflammation 56 AACR Meeting 56 Neurodegenerative Disease 56 Applied Polymer 56 MD FAHA 56 EULAR Annual 56 Congressionally Directed Medical 56 Acute Treatment 56 Soc Sci Med 56 Haematology Oncology 56 Ovarian Cancers 56 Lung Transplantation 56 histone deacetylase HDAC inhibitor 56 Society CTOS 56 Human Retroviruses 56 Primera Bioscience 56 fosbretabulin 56 Cellular Physiology 56 Psychologist Clinical 56 Crofelemer budesonide foam 56 Oral Presentations 56 recurrent glioblastoma multiforme 56 Gynecologic 56 Group RTOG 56 recurrent malignant glioma 56 Protein Folding 56 Bafetinib 56 Pediatric Infectious Diseases 56 Gynecologic Oncology 56 Cancer J Clin 56 Pregnancy Registry 56 kidney urologic 56 Releases Podcast On 56 Guidelines Issued 56 Neuro Oncology Program 56 FRSQ 56 Cancer Gene Therapy 56 Physical Therapy PTJ 56 Cardiovascular Interventions 56 Evoltra ® 56 Talpaz 56 TCGA Pilot Project 56 Systemic Lupus Erythematosus SLE 56 Liprotamase 56 Abstract Number 56 PhD DSc 56 John C. Ruckdeschel 56 NPC 1C 56 Now Accepting Nominations 56 Earns Accreditation 56 Neonatal Nursing 56 Therapeutic Competitors Companies 56 Nasdaq IDRA today 56 Kidney Disease Education 56 Novel Vaccine 56 Vascular Medicine 56 initiated Phase 1b 56 Geriatric Oncology 56 Innate Immunity 56 Cardiol 56 Slow Progression 56 Mutagenesis 56 Urology Gynecology 56 Neurologic Diseases 56 Ocular Pharmacology 56 Neoplasia 56 Pharmacopeial Convention 56 Clinical Neurosciences 56 Treating Chronic 56 Selects BoardVantage 56 FSCAI 56 Severe Sepsis 56 Immunogenetics 56 Endovascular Valve Edge 56 Urocortin 2 56 AACR San Antonio 56 Statistical Methods 56 Agios Pharmaceuticals 56 Addario Lung Cancer 56 Acute Liver Failure 56 Neural Repair 56 metastatic pancreatic 56 rPA Anthrax Vaccine 56 Glucosamine Chondroitin Arthritis 56 Hepatocellular Carcinoma 56 Minimally Invasive Spine Surgery 56 Castration Resistant Prostate Cancer 56 FRCPath 56 SinuNase ™ 56 NCI Clinical Trials 56 intravesical infusion therapy 56 telomerase inhibitor drug 56 Retrovirus 56 Post Doctoral Fellowship 56 Biodesix 56 Research www. elsevier.com 56 Coronary Revascularization 56 BioNumerik 56 Vaccinology 56 product TNFerade TM 56 Epeius Biotechnologies Corporation 56 Cancer Epidemiol Biomarkers Prev 56 Multidrug Resistant 56 Retrovirology 56 EDRN 56 vitro pharmacology 56 Rhinosinusitis 56 Luigi Ferrucci 56 apricitabine ATC 56 Reproductive Genetics 56 Immunodeficiencies 56 Institute BRNI 56 Neurologic Disorders 56 human IgG1 monoclonal 56 Microbial Pathogenesis Seminar 56 Translational Genomics 56 hyaluronidase enzyme 56 Cloretazine ® 56 Neurobiological 56 Clinical Lipidology 56 Delipidation 56 Pathology Microbiology 56 Urologic 56 FASN 56 FASHP 56 including eniluracil ADH 56 Cancer Inst 56 ASNR 56 Qualified Therapeutic Discovery 56 Autoimmunity Research 56 Metabolic Bone Disease 56 #-# PMID # 56 Manja Bouman CEO 56 First Patient Enrolled 56 Investigational Drug 56 Ph.D. MD hc 56 Fonds de la recherche 56 Appropriateness Criteria 56 Diabetology 56 Monoclonal antibody 56 adult mesenchymal stem 56 theAmerican Journal 56 preclinical efficacy 56 Advanced Wound Healing 56 Systemic Delivery 56 CaPSURE 56 demonstrated antitumor activity 56 Hematological Cancers 56 Pfizer Ophthalmics 56 Postdoctoral Fellowships 56 TNFerade ™ 56 NASDAQ HLCS 56 Preclinical Data 56 Amorcyte 56 NIH Vaccine 56 acetonide FA 56 Antibody Discovery 56 CANCER http:/www.interscience.wiley.com/cancer-neChardham Yatra 56 Visual Neuroscience 56 MEND CABG II 56 PERSEUS clinical program 56 Platinum Resistant Ovarian 56 PROactive Study 56 Acute Heart Failure 56 Receives CE Marking 56 Pancreas Transplant 56 Catheter Associated 56 Neuroradiology 56 anti botulism antibody 56 Gastrointestinal Disorders 56 Biostatistician 56 Hepatocellular 56 Translational Science Award 56 www.cancerconsultants.com 56 Defense Congressionally Directed 56 Vascular Targeting Agents 56 Poster Presentation 56 Distinguished Investigator 56 Cochrane Database Syst Rev. 56 ASCO GU 56 mitogen activated ERK kinase 56 Sc.D. MPH 56 mTOR mammalian target 56 Vascular Disrupting Agent 56 Developmental Neuroscience 56 Protein Structure 56 please visit www.advaxis.com 56 Musculoskeletal Disorders 56 Prof. Gozes 56 Cell Proliferation 56 Microbiome 56 Influenza Vaccine Production 56 Genitourinary Oncology 56 Cardiac Imaging 56 Gene Therapy ASGT 56 II Clinical Trial 56 CT Colonography Trial 56 Prognostic Factors 56 cathepsin K inhibitor 56 Integrative Oncology 56 Beta Cell Biology 56 ID NCT# 56 Stem Cell Transplant 56 Shows Statistically Significant 56 Monographs 55 & Rheumatism journal 55 multicenter Phase II 55 Diagnostic Criteria 55 Neuromuscular Research 55 Clinical Dermatology 55 ThermoDox R 55 Childhood Brain Tumor 55 please visit http:/www.sunesis.com 55 Solid Tumors 55 Einstein Montefiore 55 Research Traineeship 55 Myocet 55 Neural Stem Cells 55 LSRO 55 DNA methyltransferase inhibitors 55 evaluating Actimmune 55 Rangeland Ecology 55 NSF Integrative Graduate 55 NAACCR 55 Receives Favorable 55 Lipid Metabolism 55 Severe Chronic Neutropenia 55 assn.org 55 Pharma Merck Serono 55 Antitumor 55 journal Molecular Pharmaceutics 55 Eamonn Quigley 55 Oncological Sciences 55 Biobehavioral 55 Transplant Patients 55 Submits Application 55 doi #.#/S#-# 55 Clinical Neurology 55 Pediatric Allergy 55 Clinical Oncology ASCO Gastrointestinal 55 Regulatory Toxicology 55 Fonds de la Recherche 55 programs visit http:/www.nih.gov/ 55 PATH MVI 55 Pharmacoeconomic 55 Clinician Scientist 55 Neurological Disorder 55 CAMPATH 55 Stephen Kingsmore 55 Brain Stimulation 55 Lenocta 55 Approves Stock Repurchase 55 Interagency Coordinating Committee 55 Podium Presentation 55 ASSERT 55 Cancer iSBTc 55 Molecular Cell Biology 55 Clinical Pharmacy 55 Aeolus Pharmaceuticals Announces 55 FRCPC 55 thetreatment 55 Circulation Cardiovascular Genetics 55 Pediatric Pharmacology 55 Brentuximab Vedotin SGN 55 telomerase therapeutic 55 Ostabolin C TM 55 transthyretin TTR mediated amyloidosis 55 Sidney Kimmel Cancer 55 Lankenau Institute 55 SCIB1 55 IND Application 55 TB Vaccine 55 Awards Winners Announced 55 Abiraterone Acetate 55 Neuroprotection 55 Nutritional Biochemistry 55 Merck Serono Nycomed 55 Breast Carcinoma 55 Metabolic Bone Diseases 55 Successful Outcome 55 TKB# 55 Genetic Variation 55 Dana-Farber/Children s Hospital 55 Post Doctoral Fellow 55 Phase III Psoriasis 55 Therapeutic Discovery 55 Virion Systems 55 Organometallic Chemistry 55 Triapine 55 IND Filing 55 Tissue Repair 55 Cancer Institute www.cancer.gov 55 Vaccine Awareness 55 seliciclib CYC# 55 Inflammatory Bowel Diseases 55 AVN# Phase 55 Prodarsan R 55 SfN 55 Consultant Paediatric 55 Surgical Oncology SSO 55 Cognitive Deficits 55 interferon gamma 1b 55 ALTROPANE R 55 MEND CABG 55 rALLy clinical trial 55 Romidepsin 55 Retina Specialists 55 Study Validates 55 DAPT Study 55 bazedoxifene conjugated estrogens 55 journal Biomacromolecules 55 Am J Pathol 55 DOI #.# 55 Neuropathology 55 #:#-# [022] 55 Developmental Origins 55 ZFNs clinical trials 55 Preterm Birth 55 Receives Approval From 55 VentiRx Pharmaceuticals 55 Quadrivalent 55 trastuzumab DM1 T DM1 55 Cardiac Electrophysiology 55 refractory chronic lymphocytic 55 Delcath Phase III 55 Br J Cancer 55 Tibotec BVBA 55 Elects Officers 55 Receives Accreditation 55 Ann Surg